# Chronic Hepatitis B Virus Infection: Developing Drugs for Treatment - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/chronic-hepatitis-b-virus-infection-developing-drugs-for-treatment/1ca15a4e-3e51-4f12-8e00-cbe8778e2304

> FDA guidance document: Chronic Hepatitis B Virus Infection: Developing Drugs for Treatment. Issue date: April 07, 2022. Get complete insights and analysis.

---

## Details

- Title: Chronic Hepatitis B Virus Infection: Developing Drugs for Treatment
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2022-04-07
- Last Changed: 2022-10-27
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-3903">FDA-2018-D-3903</a>

## Related Documents

- [Vulvovaginal Candidiasis:  Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/vulvovaginal-candidiasis-developing-drugs-for-treatment/3c14a50c-15d0-4ad3-94ec-76a32afa2bdb)
- [Chronic Hepatitis C Virus Infection:  Developing Direct-Acting Antiviral Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/chronic-hepatitis-c-virus-infection-developing-direct-acting-antiviral-drugs-for-treatment-guidance-for-industry/930fbcbb-8430-4e5f-ad06-452dba6d03ff)
- [Community-Acquired Bacterial Pneumonia:  Developing Drugs for Treatment](https://www.globalkeysolutions.net/guidances/guidance-document/community-acquired-bacterial-pneumonia-developing-drugs-for-treatment/377d93dd-9e6b-491f-92e9-51b07893cc2b)